Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.5K
Overview
47.5K
Leaky Scanning02:28

Leaky Scanning

5.3K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K
Viral Recombination00:57

Viral Recombination

24.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.1K
Acute Pharyngitis01:30

Acute Pharyngitis

2.3K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[STIKO Recommendation: MF59-Adjuvanted Influenza Vaccine for Individuals ≥ 60 Years of Age].

Deutsche medizinische Wochenschrift (1946)·2026
Same author

MMW Fortschritte der Medizin·2026
Same author

Real-world effectiveness and antibody responses of BNT162b2 vaccination in long-term care residents: A retrospective case-control study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

MMW Fortschritte der Medizin·2026
Same author

[Neuropsychological examinations at the Memory Clinic].

MMW Fortschritte der Medizin·2026
Same author

[Geriatric patients in intensive care - more than just guidelines].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Oct 29, 2025

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.5K

[Influenza].

Anja Kwetkat1, Hans Jürgen Heppner2,3, Anne-Sophie Endres4

  • 1Klinik für Geriatrie, Universitätsklinikum Jena, Bachstraße 18, 07743, Jena, Deutschland. Anja.kwetkat@med.uni-jena.de.

Der Internist
|July 8, 2021
PubMed
Summary
This summary is machine-generated.

Influenza vaccination is crucial for older adults, but uptake remains low in Germany. New high-dose vaccines are recommended, yet confidence and risk perception barriers hinder achieving vaccination targets.

Keywords:
ElderlyFlu vaccinesHuman fluVaccinationVaccination rates

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.1K
Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy
08:01

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy

Published on: August 17, 2018

8.5K

Related Experiment Videos

Last Updated: Oct 29, 2025

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.5K
Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.1K
Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy
08:01

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy

Published on: August 17, 2018

8.5K

Area of Science:

  • Gerontology
  • Immunology
  • Public Health

Background:

  • Influenza poses the highest mortality risk among infectious diseases, disproportionately affecting individuals aged 60 and older.
  • Immune senescence in older adults increases susceptibility to severe influenza complications and reduces vaccine efficacy.
  • Despite advancements in vaccine technology, influenza vaccination coverage in Germany falls short of the World Health Organization's 75% target for the elderly.

Purpose of the Study:

  • To review the current recommendations for influenza vaccination in individuals aged 60 and older.
  • To identify barriers to influenza vaccination uptake in this demographic.
  • To discuss strategies for improving vaccination coverage.

Main Methods:

  • Review of current influenza vaccination guidelines and recommendations from the Standing Committee on Vaccination (STIKO).
  • Analysis of factors contributing to underutilization of influenza vaccines in Germany.
  • Examination of emerging strategies to enhance vaccine accessibility and uptake.

Main Results:

  • Germany has recommended a quadrivalent, inactivated high-dose influenza vaccine as the standard for individuals aged 60 and older.
  • Key barriers to vaccination include low confidence in vaccine effectiveness, underestimation of influenza risks, and implementation challenges.
  • Initiatives like pharmacy-based vaccination services are being introduced to improve access.

Conclusions:

  • Enhanced immunogenic vaccines offer improved protection for older adults against influenza.
  • Addressing vaccine hesitancy and improving risk perception are critical for increasing vaccination rates.
  • Further strategies are necessary to fully leverage influenza vaccination's potential in protecting vulnerable elderly populations.